Category Matches
- 11β-HSD Inhibitor
- 5-a-reductase Inhibitors
- 5-HT1 Receptors - Analgesics
- 5-HT1 Receptors - Antidepressant
- 5-HT1 Receptors - Antipsychotic
- 5-HT1 Receptors - Anxiolytic
- 5-HT1 Receptors - Cognition Enhancing
- 5-HT1 Receptors - Hypnotics
- 5-HT1 Receptors - Sedatives
- 5-HT2 Receptors - Analgesics
- 5-HT2 Receptors - Antidepressant
- 5-HT2 Receptors - Antipsychotic
- 5-HT2 Receptors - Anxiolytic
- 5-HT2 Receptors - Cognition Enhancing
- 5-HT2 Receptors - Hypnotics
- 5-HT2 Receptors - Neurodegenerative Diseases
- 5-HT2 Receptors - Sedatives
- 5-HT3 Receptors - Analgesics
- 5-HT3 Receptors - Antidepressant
- 5-HT3 Receptors - Antipsychotic
- 5-HT3 Receptors - Anxiolytic
- 5-HT3 Receptors - Cognition Enhancing
- 5-HT3 Receptors - Hypnotics
- 5-HT3 Receptors - Sedatives
- 5-HT5 Receptors - Analgesics
- 5-HT5 Receptors - Antidepressant
- 5-HT5 Receptors - Antipsychotic
- 5-HT5 Receptors - Anxiolytic
- 5-HT5 Receptors - Cognition Enhancing
- 5-HT5 Receptors - Neurodegenerative Diseases
- 5-HT5 Receptors - Sedatives
- 5-HT6 Receptors - Analgesics
- 5-HT6 Receptors - Antidepressant
- 5-HT6 Receptors - Antipsychotic
- 5-HT6 Receptors - Anxiolytic
- 5-HT6 Receptors - Cognition Enhancing
- 5-HT6 Receptors - Neurodegenerative Diseases
- 5-HT6 Receptors - Sedatives
- 5-HT7 Receptors - Analgesics
- 5-HT7 Receptors - Antidepressant
- 5-HT7 Receptors - Antipsychotic
- 5-HT7 Receptors - Anxiolytic
- 5-HT7 Receptors - Cognition Enhancing
- 5-HT7 Receptors - Sedatives
- 5-Lipoxygenase Inhibitors
- 5-α-Reductase Inhibitors
- a-Glucosidase Inhibitors
- ACE Inhibitors
- acetoxychaviol
- Acetyl-CoA Carboxylase Inhibitor
- Adenosine Receptors - Analgesics
- Adenosine Receptors - Antiepileptics and Anticonvulsants
- Adenosine Receptors - Anxiolytic
- Adenosine Receptors - Cognition Enhancing
- Adenosine Receptors - Neurodegenerative Diseases
- Adenosine Receptors - Sedatives
- Adrenal Hormones and Modulators
- Adrenergic Receptors - Analgesics
- Adrenergic Receptors - Anesthetic
- Adrenergic Receptors - Antidepressant
- Adrenergic Receptors - Antiepileptics and Anticonvulsants
- Adrenergic Receptors - Antipsychotic
- Adrenergic Receptors - Anxiolytic
- Adrenergic Receptors - Cognition Enhancing
- Adrenergic Receptors - Hypnotics
- Adrenergic Receptors - Neurodegenerative Diseases
- Adrenergic Receptors - Sedatives
- aflatoxin
- Androgen Receptor Modulators
- Androgen Synthesis Inhibitors
- Angiotensin II Inhibitors
- Anti-inflammatory
- anti-inflammatory
- Anti-mitotics
- Anti-protozoal
- Antihistamines - Therapies for Respiratory Diseases and Allergy Management
- Antimitotics
- Antimitotics
- Antiprogestogens
- Apitolisib
- Appetite Modulators
- Aromatase Inhibitors - Anticancer
- Aromatase Inhibitors - Immunology
- Beta-Adrenergic Receptor Antagonists
- Blog Post
- Ca2+ Channel Blockers - Vasodilatory
- Ca2+-sensing Receptors - Neurodegenerative Diseases
- Calcitonin
- Cannabinoid Receptors - Analgesics
- Cannabinoid Receptors - Antidepressant
- Cannabinoid Receptors - Anxiolytic
- Cannabinoid Receptors - Sedatives
- Captopril
- Cardiomodulatory
- CCK Receptor Antagonists
- CCK Release Inhibitors
- CCK Release Stimulators
- clostomicin
- Corticosteroids and Modulators
- Corticotropin Releasing Factor
- cryptotanshinone
- CYP17A1 Inhibitors
- Cytidine/Cytosine
- D1 Receptors - Analgesics
- D1 Receptors - Anesthetic
- D1 Receptors - Antidepressant
- D1 Receptors - Antipsychotic
- D1 Receptors - Anxiolytic
- D1 Receptors - Cognition Enhancing
- D1 Receptors - Neurodegenerative Diseases
- D1 Receptors - Sedatives
- D2 Receptor Antagonists
- D2 Receptors - Analgesics
- D2 Receptors - Anesthetic
- D2 Receptors - Antidepressant
- D2 Receptors - Antipsychotic
- D2 Receptors - Anxiolytic
- D2 Receptors - Cognition Enhancing
- D2 Receptors - Neurodegenerative Diseases
- D2 Receptors - Sedatives
- D3 Receptors - Analgesics
- D3 Receptors - Antidepressant
- D3 Receptors - Antipsychotic
- D3 Receptors - Anxiolytic
- D3 Receptors - Cognition Enhancing
- D3 Receptors - Neurodegenerative Diseases
- D3 Receptors - Sedatives
- D4 Receptors - Analgesics
- D4 Receptors - Antidepressant
- D4 Receptors - Antipsychotic
- D4 Receptors - Anxiolytic
- D4 Receptors - Cognition Enhancing
- D4 Receptors - Neurodegenerative Diseases
- D4 Receptors - Sedatives
- D5 Receptors - Antidepressant
- D5 Receptors - Antipsychotic
- D5 Receptors - Anxiolytic
- D5 Receptors - Cognition Enhancing
- D5 Receptors - Sedatives
- DA Receptor Signaling - Analgesics
- DA Receptor Signaling - Anesthetic
- DA Receptor Signaling - Antidepressant
- DA Receptor Signaling - Antipsychotic
- DA Receptor Signaling - Anxiolytic
- DA Receptor Signaling - Cognition Enhancing
- DA Receptor Signaling - Neurodegenerative Diseases
- DA Receptor Signaling - Sedatives
- Dihydrofolate Reductase Inhibitors
- DNA and RNA Synthesis Inhibitors
- Dopamine Receptor Inhibitors
- DOT1L Histone Methyltransferase
- DPP-4 Inhibitors
- Eicosanoid Inhibitors
- Endothelin Receptor Antagonists
- Ergosterol Inhibitors
- Estrogen Receptor Inhibitors
- etoposide
- eukaryotic initiation factor (PERK)
- EZH2 Histone Methyltransferase
- Factor Xa Inhibitors
- Furans - Other nucleic acid inhibitors
- Gastric Inhibitory Peptide
- Gastrointestinal Motility Modulators
- guanine nucleotide exchange factor
- HDAC inhibitor
- Histamine Receptors - Analgesics
- Histamine Receptors - Antidepressant
- Histamine Receptors - Antipsychotic
- Histamine Receptors - Anxiolytic
- Histamine Receptors - Cognition Enhancing
- Histamine Receptors - Hypnotics
- Histamine Receptors - Neurodegenerative Diseases
- Histamine Receptors - Sedatives
- Histone Deacetylase
- HMG-CoA Reductase Inhibitors (Statins)
- Hormone Receptor Modulators
- huntington's
- Imidazoline Receptors - Analgesics
- Imidazoline Receptors - Antipsychotic
- Imidazoline Receptors - Cognition Enhancing
- Imidazoline Receptors - Neurodegenerative Diseases
- Imidazoline Receptors - Sedatives
- Immunomodulatory
- Immunostimulatory
- Inhibitors of other enzymes
- Integrase Inhibitors
- Kinesin Inhibitors
- Leukotriene Receptor Antagonists
- M2 Protein Inhibitors
- Marine Toxins
- Melatonin Receptors - Analgesics
- Melatonin Receptors - Antidepressant
- Melatonin Receptors - Anxiolytic
- Melatonin Receptors - Hypnotics
- Melatonin Receptors - Neurodegenerative Diseases
- Melatonin Receptors - Sedatives
- Microtubule Polymerization/Depolymerization Inhibitors
- mTOR
- Muscarininc Acetylcholine Receptor Inhibitors
- mycotoxin
- Mycotoxins
- NCCT Inhibitors (Thiazide/Thiazide-like diuretics)
- Neuraminidase Inhibitors
- Neuromodulatory
- Neurotoxins
- Nitrovasodilators
- NKCC1 Inhibitors (Loop Diuretics)
- NMDA Receptors - Neurodegenerative Diseases
- NSAIDs: COX-1 Inhibitors
- NSAIDs: COX-2 Inhibitors
- nu2058
- odontoblast
- Opioid Receptor Agonists
- Opioid Receptor Antagonists
- Opioid Receptors - Analgesics
- Opioid Receptors - Anesthetic
- Opioid Receptors - Antidepressant
- Opioid Receptors - Antiepileptics and Anticonvulsants
- Opioid Receptors - Anxiolytic
- Opioid Receptors - Cognition Enhancing
- Opioid Receptors - Neurodegenerative Diseases
- Opioid Receptors - Sedatives
- Orexin Receptors - Sedatives
- Other Hormones and Modulators
- Other Nucleic Acid Inhibitors
- Others - Ergosterol Inhibitors
- Others - Other nucleic acid inhibitors
- outofstock
- Oxytocin
- pentoxifylline
- Phytoestrogens
- phytosterol
- Progestogens/Progestins
- Prostaglandin D Synthase Inhibitors
- Protease Inhibitors
- Protein synthesis Inhibitors
- Proton Pump Inhibitors
- Renin Inhibitors
- Reverse Transcriptase Inhibitors
- ritonavir
- SB-203580
- Serine/Threonine Kinase Inhibitors
- Serotonin (5-HT3) Receptor Inhibitors
- Serotonin Receptors - Analgesics
- Serotonin Receptors - Antidepressant
- Serotonin Receptors - Antipsychotic
- Serotonin Receptors - Anxiolytic
- Serotonin Receptors - Cognition Enhancing
- Serotonin Receptors - Hypnotics
- Serotonin Receptors - Neurodegenerative Diseases
- Serotonin Receptors - Sedatives
- Sex steroids and Modulators
- Sigma Receptors - Antidepressant
- Sigma Receptors - Antiepileptics and Anticonvulsants
- Sigma Receptors - Antipsychotic
- Sigma Receptors - Anxiolytic
- Sigma Receptors - Cognition Enhancing
- Sigma Receptors - Neurodegenerative Diseases
- Sigma Receptors - Sedatives
- Somatostatin Agonists
- Stem Cell Modulators
- Steroids Hormones and Modulators
- streptogramins
- Therapies for Respiratory Diseases and Allergy Management
- Thrombin Inhibitors
- Thromboxane Receptor Antagonists
- Thyroid Hormones and Modulators
- Tocolytics
- togaviridae
- Top Menu
- TOPK
- Topoisomerase
- Topoisomerase Inhibitors
- tosufloxacin
- Transcription Factor Modifiers
- Trk Receptors - Cognition Enhancing
- Trk Receptors - Neurodegenerative Diseases
- tryptophan
- Tubulin Inhibitors
- Tyrosine Kinase Inhibitors
- Vasodilatory
- Viral Fusion and Entry Inhibitors
- α1-adrenergic Receptor Antagonists - Antihypertensive
- α1-adrenergic Receptor Antagonists - Vasodilatory
- α2-adrenergic Receptor Agonists
- β Cell Proliferation Activator
- β-Glucan Synthase Inhibitors (echinocandins)
- β-lactamase inhibitors
Product Matches
- D0375Dasatinib Monohydrate
Abl, PDGFR, EphR, Src, k-Kit, FYN, LCK, HCK inhibitor.
≥98% - D023721Dasatinib
Multikinase inhibitor.
≥99% - The Effect of Microtubule Destabilizing Agents on Docetaxel-Resistant Breast Cancer Cells.Resistance to chemotherapeutics is a common adverse event in the treatment of br...
- I4802Imatinib Mesylate
Abl, c-Kit, PDGFR inhibitor.
≥98% - β-Cembrenediol Demonstrates Beneficial Effects in Models of Parkinson’s DiseaseA recent study published in Frontiers in Neuroscience reports beneficial effects...
- A7460Asparaginase
Catalyzes hydrolysis of asparagine.
≥98% - A5072Amsacrine
Acridine derivative, DNA intercalator; topoisomerase II inhibitor, hERG K+ ch...
≥98% - B7973Busulfan
Alkyl sulfonate; DNA alkylator.
≥98% - A9714AZD-1152-HQPA
AurKA/B inhibitor.
≥98% - P577520Ponatinib
pan-Bcr-Abl tyrosine kinase inhibitor.
≥99% - T4400TL-32711
Smac mimetic; IAP inhibitor.
≥98% - I4800Imatinib free base
Inhibitor of Abl, c-Kit, and PDGFR.
≥99% - C9778Cytarabine
Pyrimidine nucleoside (cytidine) analog; DNA chain terminator, DNA polymerase...
≥98% - A0776ABT-199
BH3 mimetic; Bcl-2 inhibitor.
≥99% - I7155Isoindigo
Potential AhR binding agent.
≥98% - M3379Mitoxantrone Dihydrochloride
Anthracenedione, DNA intercalator; Pim-1 inhibitor.
≥98% - H5750Homoharringtonine
Alkaloid found in Cephalotaxus; ribosomal protein synthesis inhibitor.
≥97% - F4782Fludarabine Phosphate
Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase...
≥98% - H0169Harringtonine
Cephalotaxine alkaloid originally found in Cephalotaxus; ribosomal protein sy...
≥98% - P0932PCI-32765
BTK and IL-2-inducible kinase inhibitor.
≥99%